Braun Samuel J 13D and 13G filings for Zevra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-12 4:03 pm Sale | 2022-01-04 | 13G | Zevra Therapeutics, Inc. ZVRA | Braun Samuel J | 3,021,660 8.600% | -355,900 (-10.54%) | Filing |
| 2021-12-01 08:25 am Purchase | 2021-11-30 | 13D | Zevra Therapeutics, Inc. ZVRA | Braun Samuel J | 3,377,560 9.600% | 222,560 (+7.05%) | Filing |
| 2021-05-17 4:43 pm Purchase | 2021-05-10 | 13G | Zevra Therapeutics, Inc. ZVRA | Braun Samuel J | 3,155,000 11.100% | 1,098,500 (+53.42%) | Filing |
| 2021-04-19 5:12 pm Purchase | 2021-04-09 | 13G | Zevra Therapeutics, Inc. ZVRA | Braun Samuel J | 2,056,500 7.200% | 2,056,500 (New Position) | Filing |